- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
Papers: 18 Mar 2023 - 24 Mar 2023
RESEARCH TYPE:
Clinical, Pediatric
Human Studies, Pharmacology/Drug Development
PAIN TYPE:
Migraine/Headache
2023 Feb 04
Pediatr Neurol
142
Headache is a common presenting condition for patients seen in the pediatric emergency department (ED). Intranasal (IN) sumatriptan is a well-tolerated and safe abortive treatment for migraine headache, but it is infrequently administered in pediatric EDs. In this study we characterize an ED migraine pathway that uses IN sumatriptan as a first-line treatment.